Until recently, CBD was available in forms with a pharmaceutical emphasis, such as tablet supplements, skin gels, vapes or combined with a base oil such as coconut or olive. However, increased consumer awareness of CBD has opened the doors to a plethora of new dosage forms. Edibles are projected to be the fastest growing category of CBD-containing consumer products sold in mainstream retail outlets by 2024, adding $5.7 billion in revenue by that year, per IRI/BDS Analytics.